The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I trial of lorlatinib in patients with ALK-driven refractory or relapsed neuroblastoma: A New Approaches to Neuroblastoma Consortium study.
 
Kelly C. Goldsmith
No Relationships to Disclose
 
Kimberly Kayser
No Relationships to Disclose
 
Susan G. Groshen
Employment - Pfizer (I)
 
Marc Chioda
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
Consulting or Advisory Role - Pfizer
 
Holger C. Thurm
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Joseph Chen
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Gerson Peltz
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Meaghan Granger
No Relationships to Disclose
 
John Maris
No Relationships to Disclose
 
Katherine K. Matthay
No Relationships to Disclose
 
Suzy Ghazarian
No Relationships to Disclose
 
Julie R. Park
No Relationships to Disclose
 
Esther Berko
No Relationships to Disclose
 
Araz Marachelian
Research Funding - Pfizer (Inst); United Therapeutics (Inst)
 
Yael P. Mosse
No Relationships to Disclose